Cargando…
Neuroblastoma treatment in the post-genomic era
Neuroblastoma is an embryonic malignancy of early childhood originating from neural crest cells and showing heterogeneous biological, morphological, genetic and clinical characteristics. The correct stratification of neuroblastoma patients within risk groups (low, intermediate, high and ultra-high)...
Autores principales: | Esposito, Maria Rosaria, Aveic, Sanja, Seydel, Anke, Tonini, Gian Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5299732/ https://www.ncbi.nlm.nih.gov/pubmed/28178969 http://dx.doi.org/10.1186/s12929-017-0319-y |
Ejemplares similares
-
Combating autophagy is a strategy to increase cytotoxic effects of novel ALK inhibitor entrectinib in neuroblastoma cells
por: Aveic, Sanja, et al.
Publicado: (2015) -
The zebrafish as a model for studying neuroblastoma
por: Corallo, Diana, et al.
Publicado: (2016) -
Chromosome instability in neuroblastoma
por: Fusco, Pina, et al.
Publicado: (2018) -
Resistance to receptor tyrosine kinase inhibitors in solid tumors: can we improve the cancer fighting strategy by blocking autophagy?
por: Aveic, Sanja, et al.
Publicado: (2016) -
Neuroblastoma by chance
por: Tonini, Gian Paolo
Publicado: (2019)